Overview

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Robert Silbergleit
Collaborators:
Medical University of South Carolina
National Institute of Neurological Disorders and Stroke (NINDS)
University of California, San Francisco
Treatments:
Anticonvulsants
Lorazepam
Midazolam
Criteria
Inclusion Criteria:

- Paramedics or reliable witnesses verify 5 minutes of either continuous seizure
activity or of repeated convulsive seizure activity where the patient does not regain
consciousness (operationally defined as meaningful speech or obeying commands) between
seizures.

- Patient is still seizing at the time of paramedic treatment with study medications.

- Estimated weight equal to or greater than 13 kg.

- Subject to be transported to a RAMPART participating hospital.

Exclusion Criteria:

- Major trauma as the precipitant of the seizure

- Hypoglycemia (as defined by local EMS protocol or a glucose < 60 mg/dL)

- Known allergy to midazolam or lorazepam

- Cardiac arrest or heart rate (HR) <40 beats per minute

- Sensitivity to benzodiazepines

- Medical alert tag marked with "RAMPART declined"

- Prior treatment of this seizure with diazepam autoinjector as part of another study

- Known pregnancy

- Prisoners